Farewell to Chris Richardson

Chris Richardson joined the lab as a Postdoctoral Fellow in July 2014 and made huge advances in human gene editing. He developed new ways to improve NHEJ and HDR, plus discovered out that genome editing in human cells works via the Fanconi Anemia Pathway. Three major first author papers in three years – not bad! Chris will be joining Spotlight Therapeutics as a Group Leader, and may have some additional career news to share soon. We wish you success in all your future endeavors!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

November 26, 2025

Congratulations to Fedor!

We are delighted to announce that Fedor has successfully defended his PhD. During his doctoral research, Fedor demonstrated remarkable dedication and perseverance,...

November 21, 2025

Congratulations to Sebastian!

We are happy to announce that Seba has successfully completed his PhD, built on passionate and persistent research into synthetic lethality in the DNA damage...

November 12, 2025

Congratulations to Moritz!

Huge congratulations to Moritz on the successful defense of his PhD thesis! His outstanding and dedicated work led to the development of scOUT-seq (single-cell...

News Archive

Tweets